246 related articles for article (PubMed ID: 25115189)
1. The bidirectional tumor--mesenchymal stromal cell interaction promotes the progression of head and neck cancer.
Kansy BA; Dißmann PA; Hemeda H; Bruderek K; Westerkamp AM; Jagalski V; Schuler P; Kansy K; Lang S; Dumitru CA; Brandau S
Stem Cell Res Ther; 2014 Aug; 5(4):95. PubMed ID: 25115189
[TBL] [Abstract][Full Text] [Related]
2. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
[TBL] [Abstract][Full Text] [Related]
3. Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma.
Schuler PJ; Westerkamp AM; Kansy BA; Bruderek K; Dissmann PA; Dumitru CA; Lang S; Jackson EK; Brandau S
Immunobiology; 2017 Jan; 222(1):66-74. PubMed ID: 26898925
[TBL] [Abstract][Full Text] [Related]
4. Secretory Autophagy in Cancer-Associated Fibroblasts Promotes Head and Neck Cancer Progression and Offers a Novel Therapeutic Target.
New J; Arnold L; Ananth M; Alvi S; Thornton M; Werner L; Tawfik O; Dai H; Shnayder Y; Kakarala K; Tsue TT; Girod DA; Ding WX; Anant S; Thomas SM
Cancer Res; 2017 Dec; 77(23):6679-6691. PubMed ID: 28972076
[TBL] [Abstract][Full Text] [Related]
5. Interactions of human MSC with head and neck squamous cell carcinoma cell line PCI-13 reduce markers of epithelia-mesenchymal transition.
Böhrnsen F; Fricke M; Sander C; Leha A; Schliephake H; Kramer FJ
Clin Oral Investig; 2015 Jun; 19(5):1121-8. PubMed ID: 25346374
[TBL] [Abstract][Full Text] [Related]
6. Human Mesenchymal Stromal Cells Do Not Cause Radioprotection of Head-and-Neck Squamous Cell Carcinoma.
Rühle A; Lies M; Strack M; Perez RL; Bieber B; Thomsen AR; Bronsert P; Huber PE; Hess J; Knopf A; Wuchter P; Grosu AL; Nicolay NH
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887032
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of head and neck squamous cell carcinoma proliferation, invasion, and metastasis by tumor-associated fibroblasts in preclinical models.
Wheeler SE; Shi H; Lin F; Dasari S; Bednash J; Thorne S; Watkins S; Joshi R; Thomas SM
Head Neck; 2014 Mar; 36(3):385-92. PubMed ID: 23728942
[TBL] [Abstract][Full Text] [Related]
8. Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma.
Van Tubergen E; Vander Broek R; Lee J; Wolf G; Carey T; Bradford C; Prince M; Kirkwood KL; D'Silva NJ
Cancer; 2011 Jun; 117(12):2677-89. PubMed ID: 21656745
[TBL] [Abstract][Full Text] [Related]
9. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
[TBL] [Abstract][Full Text] [Related]
10. Irradiated fibroblasts increase interleukin-6 expression and induce migration of head and neck squamous cell carcinoma.
Suzuki S; Toyoma S; Kawasaki Y; Yamada T
PLoS One; 2022; 17(1):e0262549. PubMed ID: 35089951
[TBL] [Abstract][Full Text] [Related]
11. IL-6 antisense-mediated growth inhibition in a head and neck squamous cell carcinoma cell line.
Bran G; Götte K; Riedel K; Hörmann K; Riedel F
In Vivo; 2011; 25(4):579-84. PubMed ID: 21708999
[TBL] [Abstract][Full Text] [Related]
12. Human mesenchymal stem cells enhance cancer cell proliferation via IL-6 secretion and activation of ERK1/2.
Scherzad A; Steber M; Gehrke T; Rak K; Froelich K; Schendzielorz P; Hagen R; Kleinsasser N; Hackenberg S
Int J Oncol; 2015 Jul; 47(1):391-7. PubMed ID: 25997536
[TBL] [Abstract][Full Text] [Related]
13. Roles of mesenchymal stromal cells in the head and neck cancer microenvironment.
de Miranda MC; Melo MIA; Cunha PDS; Gentilini J; Faria JAQA; Rodrigues MA; Gomes DA
Biomed Pharmacother; 2021 Dec; 144():112269. PubMed ID: 34794230
[TBL] [Abstract][Full Text] [Related]
14. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
[TBL] [Abstract][Full Text] [Related]
15. Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).
Zhang F; Li Y; Zhang H; Huang E; Gao L; Luo W; Wei Q; Fan J; Song D; Liao J; Zou Y; Liu F; Liu J; Huang J; Guo D; Ma C; Hu X; Li L; Qu X; Chen L; Yu X; Zhang Z; Wu T; Luu HH; Haydon RC; Song J; He TC; Ji P
Oncotarget; 2017 Feb; 8(8):12968-12982. PubMed ID: 28099902
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood neutrophil granulocytes from patients with head and neck squamous cell carcinoma functionally differ from their counterparts in healthy donors.
Trellakis S; Farjah H; Bruderek K; Dumitru CA; Hoffmann TK; Lang S; Brandau S
Int J Immunopathol Pharmacol; 2011; 24(3):683-93. PubMed ID: 21978700
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation.
Liotta F; Querci V; Mannelli G; Santarlasci V; Maggi L; Capone M; Rossi MC; Mazzoni A; Cosmi L; Romagnani S; Maggi E; Gallo O; Annunziato F
Br J Cancer; 2015 Feb; 112(4):745-54. PubMed ID: 25647013
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma.
Espinosa-Cotton M; Rodman Iii SN; Ross KA; Jensen IJ; Sangodeyi-Miller K; McLaren AJ; Dahl RA; Gibson-Corley KN; Koch AT; Fu YX; Badovinac VP; Laux D; Narasimhan B; Simons AL
J Immunother Cancer; 2019 Mar; 7(1):79. PubMed ID: 30890189
[TBL] [Abstract][Full Text] [Related]
19. HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer.
Knowles LM; Stabile LP; Egloff AM; Rothstein ME; Thomas SM; Gubish CT; Lerner EC; Seethala RR; Suzuki S; Quesnelle KM; Morgan S; Ferris RL; Grandis JR; Siegfried JM
Clin Cancer Res; 2009 Jun; 15(11):3740-50. PubMed ID: 19470725
[TBL] [Abstract][Full Text] [Related]
20. The effect of tetrathiomolybdate on cytokine expression, angiogenesis, and tumor growth in squamous cell carcinoma of the head and neck.
Teknos TN; Islam M; Arenberg DA; Pan Q; Carskadon SL; Abarbanell AM; Marcus B; Paul S; Vandenberg CD; Carron M; Nor JE; Merajver SD
Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):204-11. PubMed ID: 15781759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
